Gold miners are getting smashed as an S&P/ ASX200 bull market is tipped to return

Is a bull market coming for global equities?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The S&P/ ASX200 (ASX: XJO) is up 0.7% in morning trade today on the back of a strong overnight session and week of trading for U.S. share markets after U.S. Fed chair Jerome Powell signalled to markets that it does not expect to lift cash rates again in 2019.

Warren Buffett has been regularly quoted over the last 18 months as saying whether share markets are good value or not today depends largely on the outlook for interest rates.

For example if interest or 'risk free" rates lift (the US cash rate is currently 2.4%) then markets will demand lower stock valuations to compensate for additional risks around equities.

While if cash or 'risk free' rates are held low then growth stocks become more attractive in an otherwise low return financial environment.

The US Fed appears to have stoked a return to an equity bull market this week that also has negative consequences for gold prices and gold miners. T

his is because gold is seen as a 'flight to safety' asset or something to buy as a hedge against falling markets.

Today ASX gold miners are dominating the worst performers on the local market, check out the scoreboard below:

  • St Barbara Ltd (ASX: SBM) down 30% in relation to a downgrade
  • Newcrest Mining Limited (ASX: NCM) down 0.4% to $25.39
  • Evolution Ltd (ASX: EVN) down 2% to $3.67
  • Saracen Minerals Ltd (ASX: SAR) down 3.1% to $2.79
  • Regis Resources Ltd (ASX: RRL) down 3% to $5.26
  • Northern Star Resources Ltd (ASX: NST) down 2.8% to $8.75

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed another exciting session this Tuesday.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

3 ASX shares Macquarie says will return 23% to 49%

These shares are well-positioned for a strong year.

Read more »

Two workers on a tablet at a mine site, with mining machinery behind them.
52-Week Highs

8 ASX mining shares hitting 52-week highs today

ASX mining ETFs QRE and OZR also reached new price peaks today.

Read more »

Stock market board with green numbers.
ASX Share Market News

Why is the ASX 200 having its best day in 3 weeks?

The ASX 200 is pushing higher as heavyweight sectors rally.

Read more »

Woman and man at work looking at data on a tablet at work.
Broker Notes

Buy, hold, sell: Judo Capital, Healius, BHP shares

Morgans has issued new notes on several stocks including BHP, which hit a new record today.

Read more »

Woman with her kitten on a laptop in her home office.
Broker Notes

Buy, hold, sell: Bendigo and Adelaide Bank, PLS, EOS shares

These three ASX shares posted their FY26 results this week. Find out what brokers tip next.

Read more »

A young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
ASX Share Market News

Why is everyone talking about Coles, Ramelius Resources and Woodside shares on Tuesday?

Woodside, Ramelius Resources, and Coles shares are creating a stir on Tuesday. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Bell Potter says this ASX biotech could nearly double in value

The US market is starting to open up for this company.

Read more »